Morning, ladies and gentlemen. Welcome to the 2026 annual meeting of stockholders of Rocket Pharmaceuticals, Inc. My name is Roderick Wong. I'm the Chairman of the Board of Directors, and will act as Chairman of the 2026 annual meeting of stockholders of Rocket Pharmaceuticals, Inc. I'm very happy to welcome each of you, and the company is pleased to have each of you in attendance. Before I call the meeting to order, I'd like to introduce the other members of the board and the business team who are with us in person and virtually today. The other members of the board in attendance at this meeting are Carsten Boess, Mikael Dolsten, Peter Fong, Fady Malik, Gaurav Shah, and David Southwell. The following officers of the company are also with us today: Sarbani Chaudhuri, Syed Rizvi, Jonathan Schwartz, Chris Stevens, and Martin Wilson.
Martin will act as the secretary for this meeting. In addition, I'd like to introduce Jaime Gilmore, who's in attendance as a representative of EisnerAmper, our independent registered public accounting firm. All right, the meeting will now officially come to order. We'll proceed with the formal business of the meeting as set forth in your notice of the annual meeting and proxy statement. After the formal part of the meeting, Gaurav Shah, the Chief Executive Officer of the company, will give you an opportunity to ask any questions you may have. Will the secretary please report at this time with respect to the record date, stockholders list, and the mailing of the notice of the annual meeting?
Thank you, Rod. March 24th, 2026, was set by resolution of the board of directors as the record date for today's annual meeting. We have at this meeting a complete list of the stockholders of record of the company's common stock as of March 24th, 2026. We also have affidavits certifying the proper mailing of the notice of annual meeting and required documentation to the stockholders of record of the company's common stock as of the record date.
At this time, I'd like to introduce Tracy Oates. Tracy Oates, on behalf of Broadridge Financial Solutions, has been appointed by the board to serve as Independent Inspector of Election for this meeting. Ms. Oates has taken an oath to accurately tabulate and report the results of this meeting. We'll file this oath with the records of the meeting. The function of the Inspector of Election is to decide upon the qualifications of voters, accept their votes, and when balloting on all matters is complete, to tally the final votes. Will the secretary please report at this time with respect to the existence of a quorum?
We have been informed by the Inspector of Election that proxies have been received for 80,774,659 shares of the outstanding shares of Rocket Pharmaceuticals Inc. common stock. Collectively, the votes for which these proxies were received represent approximately 74.2% of the total number of votes that may be cast by the outstanding shares. This constitutes a quorum for the meeting today. Are there any other additional proxies to be submitted to the Inspector of Election at this time? There are none reported, Rod, we can continue.
Great. We'll now proceed with the formal business of this meeting. There are four proposals to be considered by the stockholders at this meeting.
I will summarize and are more fully described in the proxy statement for this meeting, which has been filed with the Securities and Exchange Commission and mailed to stockholders. The first item of business is the election of seven directors to serve until the 2027 annual meeting of stockholders and until their successors are elected and qualified. This proposal is described in detail in the notice and proxy statement delivered to stockholders in connection with this meeting. The nominees for directors are Peter Fong as Chair, Carsten Boess, Mikael Dolsten, Fady Malik, Gaurav Shah, David Southwell, and myself, Roderick Wong. Is there any discussion regarding this proposal?
There is none, Rod, so I think we can continue. Thanks.
The second item of business is the ratification of the selection by the audit committee of the board of directors of EisnerAmper LLP as the independent registered public accounting firm of the company for the fiscal year ending December 31st, 2026. This proposal is described in detail in the notice and proxy statement delivered to stockholders in connection with this meeting. Is there any discussion regarding this proposal?
Nothing online or on the phone. We can continue.
Thanks. The third item of business is the non-binding advisory vote on the compensation for the company's named executive officers. This proposal is described in detail in the notice and proxy statement delivered to stockholders in connection with this meeting. Is there any discussion regarding this proposal?
Again, nothing online or on the phone, so I think we can go on to the last proposal.
Right. The fourth item of business is the approval of the proposed stock option exchange program. This proposal is also described in detail in the notice and proxy statement delivered to stockholders in connection with this meeting. Is there any discussion regarding this proposal?
Again, no discussions or questions. We can move on.
Thank you. That was the final proposal for today's meeting. The secretary will now open the polls and describe the voting procedures.
The time is now 9:00 A.M., and the polls are now open for voting on all matters to be presented. We will vote by proxy and in person through the virtual portal. If you have already voted by proxy, then you do not need to vote in person at this meeting unless you would like to change your vote. If there's any stockholder present, whether or not you already submitted a proxy who now wants to vote in person, please submit your votes via the virtual portal. Okay. The time is now 9:07 A.M., and the polls are now closed for voting. I ask Tracy Oates as our designated inspector of election for this meeting to tabulate and certify the results.
All right, Tracy, may we have the results of the voting when you're ready?
Yes. The preliminary report of inspector of election covering the proposals presented at this meeting is as follows. The nominees for election to the board, Peter Fong, Carsten Boess, Mikael Dolsten, Fady Malik, Gaurav Shah, David P. Southwell, and Roderick Wong, have been duly elected. The proposal to ratify the appointment of EisnerAmper LLP as the independent registered public accounting firm of the company for 2026 has been approved. The proposal to approve, on a non-binding advisory basis, the compensation of the company's named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting of Stockholders has been approved. The proposal to approve the stock option exchange program has been approved. A full tally of the votes will be published in a current report on Form 8-K, which will be filed with the Securities and Exchange Commission within four business days. Rod?
The 2026 Annual Meeting of Stockholders is now concluded. I want to thank all of you for attending today's meeting and for the interest you've shown in the affairs of our company. Gaurav Shah will now entertain questions from stockholders.
Hi. Any questions online or on the phone?
There are no questions on the phone.
All right. Thank you, everybody. This concludes the call.
This concludes today's meeting. You may disconnect.